These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38778687)
21. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO. Götze TO; Piso P; Lorenzen S; Bankstahl US; Pauligk C; Elshafei M; Amato G; Reim D; Bechstein WO; Königsrainer A; Mönig SP; Rau B; Schwarzbach M; Al-Batran SE BMC Cancer; 2021 Oct; 21(1):1158. PubMed ID: 34715810 [TBL] [Abstract][Full Text] [Related]
22. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: A retrospective cohort study. Feng F; Gao Q; Wu Y; Liu C; Yu Y; Li B; Chu K; Yi B; Cheng Q; Jiang X Eur J Surg Oncol; 2021 Sep; 47(9):2363-2368. PubMed ID: 34119376 [TBL] [Abstract][Full Text] [Related]
23. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy]. An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351 [No Abstract] [Full Text] [Related]
24. [Efficacy of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei]. Lei ZY; Ding BH; Wu QY; Luo JL; Li Z; Wang T; Wang YS; Chen YX; Huang LF; He JF; Yang XS; Guan TP; Ruan Q; Wang JH; Tang HS; Wang J; Cui SZ Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1179-1186. PubMed ID: 38110280 [No Abstract] [Full Text] [Related]
25. Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancer. Chichura A; Chambers LM; Costales AB; Yao M; Gruner M; Morton M; Rose PG; Vargas R; Michener CM; Debernardo R Gynecol Oncol; 2021 Apr; 161(1):194-201. PubMed ID: 33468319 [TBL] [Abstract][Full Text] [Related]
26. HIPEC plus EPIC paclitaxel for maximal perioperative treatments of advanced epithelial ovarian cancer. Long-term results of a pilot study. Sugarbaker PH; Stuart OA Surg Oncol; 2020 Dec; 35():441-446. PubMed ID: 33039850 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. Beeharry MK; Zhu ZL; Liu WT; Yao XX; Yan M; Zhu ZG BMC Cancer; 2019 Sep; 19(1):932. PubMed ID: 31533660 [TBL] [Abstract][Full Text] [Related]
28. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection]. Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920 [No Abstract] [Full Text] [Related]
29. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study. Sun JH; Ji ZH; Peng KW; Wu HT; Zhang Q; Yonemura Y; Li Y Int J Hyperthermia; 2016 May; 32(3):289-97. PubMed ID: 26982735 [TBL] [Abstract][Full Text] [Related]
30. Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer. Gruner M; Chambers LM; Yao M; Chichura A; Morton M; Costales AB; Horowitz M; Rose PG; Debernardo R; Michener CM Gynecol Oncol; 2021 Sep; 162(3):645-651. PubMed ID: 34247768 [TBL] [Abstract][Full Text] [Related]
31. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Quénet F; Elias D; Roca L; Goéré D; Ghouti L; Pocard M; Facy O; Arvieux C; Lorimier G; Pezet D; Marchal F; Loi V; Meeus P; Juzyna B; de Forges H; Paineau J; Glehen O; Lancet Oncol; 2021 Feb; 22(2):256-266. PubMed ID: 33476595 [TBL] [Abstract][Full Text] [Related]
32. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients. Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213 [TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Yang XJ; Huang CQ; Suo T; Mei LJ; Yang GL; Cheng FL; Zhou YF; Xiong B; Yonemura Y; Li Y Ann Surg Oncol; 2011 Jun; 18(6):1575-81. PubMed ID: 21431408 [TBL] [Abstract][Full Text] [Related]
34. Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized Study. Bazarbashi S; Badran A; Gad AM; Aljubran A; Alzahrani A; Alshibani A; Alrakaf R; Elhassan T; Alsuhaibani A; Elshenawy MA Ann Surg Oncol; 2023 Jan; 30(1):426-432. PubMed ID: 36042103 [TBL] [Abstract][Full Text] [Related]
35. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy. Newhook TE; Agnes A; Blum M; Estrella JS; Das P; Ho L; Ajani JA; Minsky BD; Mansfield P; Badgwell BD Ann Surg Oncol; 2019 May; 26(5):1394-1400. PubMed ID: 30680477 [TBL] [Abstract][Full Text] [Related]
36. Factors Associated with Resection and Survival After Laparoscopic HIPEC for Peritoneal Gastric Cancer Metastasis. White MG; Kothari A; Ikoma N; Murphy MB; Song S; Ajani J; Mansfield P; Badgwell B Ann Surg Oncol; 2020 Dec; 27(13):4963-4969. PubMed ID: 32648181 [TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials. Granieri S; Bonomi A; Frassini S; Chierici AP; Bruno F; Paleino S; Kusamura S; Germini A; Facciorusso A; Deraco M; Cotsoglou C Eur J Surg Oncol; 2021 Nov; 47(11):2757-2767. PubMed ID: 34001385 [TBL] [Abstract][Full Text] [Related]
38. Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Chen CY; Chang HY; Lu CH; Chen MC; Huang TH; Lee LW; Liao YS; Chen VC; Huang WS; Ou YC; Lung FC; Wang TY Int J Hyperthermia; 2020; 37(1):1279-1286. PubMed ID: 33198563 [TBL] [Abstract][Full Text] [Related]
39. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial]. Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918 [No Abstract] [Full Text] [Related]
40. Prognostic Analysis of Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: a Propensity Score-Matched Analysis. Liu L; Zheng L; Liu S; Zhang M; Zhang S; Jiang Z; Qin C; Wang D J Gastrointest Surg; 2023 Nov; 27(11):2297-2307. PubMed ID: 37715013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]